Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,137 | 6,070 | 7,322 | 8,931 | 1,719 |
| Other current assets | 0 | 0 | 0 | 5,481 | 5,575 |
| TOTAL | $5,164 | $6,134 | $7,397 | $14,466 | $7,294 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 3,140 | 3,341 |
| TOTAL | $N/A | $N/A | $N/A | $3,140 | $3,341 |
| Total Assets | $5,164 | $6,134 | $7,397 | $17,605 | $10,635 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 84 | 421 | 970 | 757 | 764 |
| Accrued Expenses | 143 | 512 | 261 | 200 | 100 |
| Other current liabilities | 1 | 3 | 4 | 24,329 | 15,254 |
| TOTAL | $2,293 | $2,765 | $2,950 | $27,132 | $18,028 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 58 | 75 |
| TOTAL | $N/A | $N/A | $N/A | $58 | $75 |
| Total Liabilities | $2,293 | $2,765 | $2,950 | $27,190 | $18,103 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,372 | 42,372 | 42,372 | 31,160 | 2,141 |
| Common Shares | 4 | 4 | 4 | 0 | 0 |
| Retained earnings | -111,295 | -110,958 | -110,036 | -115,468 | -113,208 |
| TOTAL | $2,871 | $3,368 | $4,447 | $-9,584 | $-7,468 |
| Total Liabilities And Equity | $5,164 | $6,134 | $7,397 | $17,605 | $10,635 |